As of 2026-09-12, the Intrinsic Value of Greenwich Lifesciences Inc (GLSI) is -7.38 USD. This GLSI valuation is based on the model Peter Lynch Fair Value. With the current market price of 15.06 USD, the upside of Greenwich Lifesciences Inc is -149.03%.
Based on its market price of 15.06 USD and our intrinsic valuation, Greenwich Lifesciences Inc (GLSI) is overvalued by 149.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.38 - -7.38 | -7.38 | -149.03% |
| P/E | (35.00) - (43.72) | (39.62) | -363.1% |
| DDM - Stable | (12.39) - (53.95) | (33.17) | -320.3% |
| DDM - Multi | (6.62) - (23.12) | (10.37) | -168.9% |
| Market Cap (mil) | 221.08 |
| Beta | 2.79 |
| Outstanding shares (mil) | 14.68 |
| Enterprise Value (mil) | 212.20 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.40% |
| Cost of Debt | 5.00% |
| WACC | 6.54% |